UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in moderate-to-severe hidradenitis suppurativa (HS). BIMZELX, the ...
During rigorous laboratory crash tests, the £20k Dongfeng Box scored just three stars in Euro NCAP's assessment, having been ...
Today's call will feature prepared comments by Will Lewis, Chair and Chief Executive Officer; Roger Adsett, Chief Operating Officer; and Sara Bonstein, Chief Financial Officer. After their comments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback